MDT - Medtronic Plc
(NaN%)
Sell
Moderate Growth and Stable●Stock Price Very High
51%
based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is 3.23%
Operating Income Growth is -8.44%
Net Income Growth is 8.51%
Earnings Per Share (EPS) Growth is 9.23%
Net Margin is 12.05%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 2.13
Debt Ratio is 0.46
Current Debt to Net Income Ratio is 1.49
Total Debt to Total Assets Ratio is 0.31
Cash Flow is MODERATE
Cash from Operations Growth is 18.3%
Capital Expenditure is High
Net Increase in Cash is Negative
Long Term Score Trend is NEUTRAL
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Medtronic Plc (MDT) - https://www.medtronic.com/
Medtronic plc is an American medical device company. The companys operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.Exchange - NEW YORK STOCK EXCHANGE INC.
Industry - Surgical and Medical Instrument Manufacturing
Sector - Manufacturing
CEO -
Employees - 95,000
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2024 and future.
Know the Stock © 2024 and future.